EUVIMEDEUVIMED entdecken
Crossref

Adrenal suppression from vamorolone and prednisone in Duchenne muscular dystrophy: results from the phase 2b clinical trial

Ahmet A, Tobin R, Dang UJ, Rooman R, Guglieri M, Clemens PR, Hoffman EP, Ward LM

Yearbook of Paediatric Endocrinology · 30.09.2025

DOI: 10.1530/ey.22.8.9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Yearbook of Paediatric Endocrinology, online erschienen am 30.09.2025. Verfasst von Ahmet A und 7 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

A, A., R, T., UJ, D., R, R., M, G., PR, C., EP, H., & LM, W. (2025). Adrenal suppression from vamorolone and prednisone in Duchenne muscular dystrophy: results from the phase 2b clinical trial. Yearbook of Paediatric Endocrinology. https://doi.org/10.1530/ey.22.8.9

Vancouver

A A, R T, UJ D, R R, M G, PR C, et al. Adrenal suppression from vamorolone and prednisone in Duchenne muscular dystrophy: results from the phase 2b clinical trial. Yearbook of Paediatric Endocrinology. 2025. doi:10.1530/ey.22.8.9

BibTeX
@article{A2025,
  author = {A, Ahmet and R, Tobin and UJ, Dang and R, Rooman and M, Guglieri and PR, Clemens and EP, Hoffman and LM, Ward},
  title = {Adrenal suppression from vamorolone and prednisone in Duchenne muscular dystrophy: results from the phase 2b clinical trial},
  journal = {Yearbook of Paediatric Endocrinology},
  year = {2025},
  doi = {10.1530/ey.22.8.9}
}
Kostenlos starten →